Andrew Ranieri

Work

Analyst Andrew Ranieri works at MORGAN STANLEY and is focused on the Healthcare sector with 180 price targets and ratings documented since 2021 spanning on 20 stocks. Analyst's average stock valuation to be materialised ratio is 37.5% with an average time for price targets to be met of 29.75 days.

Most recent stock forecast was given on GMED, Globus Medical, Inc at 09-Nov-2022.

Andrew Ranieri best performing recommendations are on TMCI (TREACE MEDICAL CONCEPTS INC).
The best stock recommendation documented was for TMCI (TREACE MEDICAL CONCEPTS INC) at 5/26/2021. The price target of $32 was fulfilled within 1 day with a profit of $2.43 (8.22%) receiving and performance score of 82.18.

Average potential price target upside

AGTI BVS GMED HAE HRC ISRG NPCE NUVA SIBN SYK TMCI ZBH ATEC AVNS BAX IART NVST OM TFX STVN
AGTI BVS GMED HAE HRC ISRG NPCE NUVA SIBN SYK TMCI ZBH ATEC AVNS BAX IART NVST OM TFX STVN